PRESS RELEASE published on 07/06/2026 at 18:30, 3 months 30 days ago Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module Oxurion NV launches Exagis eTMF module, a key milestone in building its eClinical software platform. Designed for clinical research efficiency and regulatory compliance Regulatory Compliance Clinical Research Oxurion NV Exagis ETMF Module EClinical Software Platform
BRIEF published on 06/26/2026 at 18:05, 4 months 9 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actionnariat Belgique Notification De Transparence Oxurion Opportunités Spéciales Atlas
BRIEF published on 06/26/2026 at 18:05, 4 months 9 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/26/2026 at 18:00, 4 months 9 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities II, LLC, crossing under the 3% threshold Transparency Notification Euronext Brussels Oxurion NV Shares Ownership Atlas Special Opportunities II LLC
PRESS RELEASE published on 06/26/2026 at 18:00, 4 months 9 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV erhält eine Transparenzmitteilung gemäß belgischem Recht von Atlas Special Opportunities II LLC bezüglich des Anteilsbesitzes am Unternehmen Technologie Oxurion NV Transparenzmitteilung Belgisches Recht Klinisch Forschung
BRIEF published on 06/24/2026 at 18:05, 4 months 11 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Securities Transparency Notification Oxurion Belgian Legislation Atlas Special Opportunities II
BRIEF published on 06/24/2026 at 18:05, 4 months 11 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Titres Notification De Transparence Oxurion Atlas Special Opportunities II Législation Belge
PRESS RELEASE published on 06/24/2026 at 18:00, 4 months 11 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC. Oxurion bouwt platform voor klinisch onderzoek en software Transparantiekennisgeving Euronext Brussel Oxurion NV Atlas Special Opportunities II LLC Klinisch Onderzoek
PRESS RELEASE published on 06/24/2026 at 18:00, 4 months 11 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV has received a transparency notification regarding changes in shareholding. The company is focused on technology-enabled clinical research and software platform Clinical Research Transparency Notification Shareholding Software Platform Oxurion NV
BRIEF published on 06/19/2026 at 15:50, 4 months 16 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Technology Platform Atlas Special Opportunities Oxurion
Published on 11/06/2026 at 00:53, 27 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 35 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 1 hour 25 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 2 hours ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/05/2026 at 22:05, 3 hours 15 minutes ago Innodata Reports Record Third Quarter 2026 Results
Published on 11/06/2026 at 00:05, 1 hour 15 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 3 hours 15 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 4 hours 42 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 4 hours 43 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 5 hours 34 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 6 hours 58 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 6 hours 58 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
